文献速递关节外科创伤骨科

慢性假体周围关节感染患者菌血症的发生频率如何?一项前瞻性观察性研究

How Often Does Bacteremia Occur in Patients With Chronic Periprosthetic Joint Infection? A Prospective, Observational Study.
PubMed 文献 · Clin Orthop Relat Res · 2025-01-21

前瞻性观察性研究在单中心纳入92例慢性假体周围关节感染(PJI)患者,术前血培养阳性率为15%(14/92)。调整混杂因素后,ASA III级(OR 4 [95%CI 1至21];p=0.04)和糖尿病(OR 14 [95%CI 3至100];p<0.001)与血培养阳性几率升高相关。血培养阳性组与阴性组30个月无感染假体生存率无显著差异(86% [95%CI 76%至95%] vs 91% [95%CI 88%至94%];p=0.51)。

要点

  • 慢性PJI患者术前血培养阳性率为15%(14/92),即入院后48小时内、术前采集两次血培养。
  • ASA III级患者血培养阳性OR 4(95%CI 1至21;p=0.04),糖尿病患者OR 14(95%CI 3至100;p<0.001)。
  • 血培养阳性组与阴性组30个月无感染假体生存率无显著差异(86% vs 91%;p=0.51)。

核心结论

  • 慢性PJI可能导致病原体血行播散,尤其在整体健康状况较差(如ASA III级和糖尿病患者)的患者中。
  • 作者认为,对于基线健康状况较差和携带其他植入装置的患者,选择性术前血培养可能对帮助临床医生实施早期干预措施以防止菌血症严重后果至关重要。
  • 作者指出需要更大样本、更长随访的研究来进一步验证这些发现、确保更稳健的估计,并全面评估慢性PJI中血培养阳性的危险因素。

研究设计与样本

  • 前瞻性观察性研究,在单一学术机构于2021年6月至2022年8月开展。
  • 研究期间治疗124例按改良肌肉骨骼感染学会(MSIS)标准定义的慢性PJI患者,其中87%(108/124)符合条件,最终74%(92/124)纳入分析。
  • 纳入患者均因髋或膝关节慢性PJI接受翻修手术,入院后48小时内、术前采集两次血培养,第二次于第一次完成后1小时在对侧手臂采集。
  • 纳入患者的年龄为65±13岁,BMI为28±3 kg/m²,男性占40%(37/92),髋PJI占39%(36/92),膝PJI占61%(56/92)。
  • 从指数手术至本次PJI翻修的中位(范围)时间为16个月(2至180)。

主要发现

  • 总体15%(14/92)的患者血培养阳性。
  • 调整年龄、性别、感染部位、BMI和术中分离出革兰阳性球菌后,ASA III级患者血培养阳性的OR为4(95%CI 1至21;p=0.04)。
  • 调整相同混杂因素后,糖尿病患者血培养阳性的OR为14(95%CI 3至100;p<0.001)。
  • 血培养阳性组与阴性组30个月无感染假体生存率的Kaplan-Meier估计值无差异:阳性组86%(95%CI 76%至95%)vs 阴性组91%(95%CI 88%至94%);p=0.51。

关键数值与推荐

  • 慢性PJI按改良MSIS标准定义。
  • 血培养阳性定义为术前两次血培养中至少一次阳性(基于分组描述)。
  • 排除标准包括:血样转运延迟6%(7/124)、样本污染2%(2/124)、晚期血行感染2%(3/124)、采样前2周内使用抗生素3%(4/124)。
  • 无患者在最低2年研究随访前失访或未达到研究终点(再感染或持续性PJI),也无数据集不完整者。

临床怎么用

  • 作者认为,对于基线健康状况较差(如ASA III级)和携带其他植入装置的患者,选择性术前血培养可能对帮助临床医生实施早期干预措施以防止菌血症严重后果至关重要。

局限性

  • 作者指出需要更大样本、更长随访的研究来进一步验证这些发现、确保更稳健的估计,并全面评估慢性PJI中血培养阳性的危险因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Bacteremia is sometimes observed in patients with prosthetic joint infection (PJI), and it is associated with a lower likelihood of infection control. However, the prevalence and association of bacteremia in chronic PJI remain unknown. QUESTIONS/PURPOSES: (1) What percentage of patients are diagnosed with bacteremia at the time of hospital admission and before surgery for chronic PJI? (2) What clinical factors are associated with positive blood cultures? (3) To what degree are positive blood cultures associated with infection-free implant survival in patients with chronic PJI? METHODS: This prospective study was conducted at a single academic institution from June 2021 to August 2022. Within the study period, we treated 124 patients for chronic PJI, defined according to the modified Musculoskeletal Infection Society (MSIS) criteria. Of those, we considered patients who underwent revision surgery because of chronic PJI of the hip or knee as potentially eligible. All patients received two blood cultures within 48 hours after admission but before surgery. The second blood culture was performed on the contralateral arm 1 hour after the first was completed. Based on that, 87% (108 of 124) of patients were eligible; 13% (16 of 124) were excluded because of delayed blood sample transfers in 6% (7 of 124) of patients, contaminated samples in 2% (2 of 124), late hematogenous infection in 2% (3 of 124), and antibiotic use within 2 weeks before sampling in 3% (4 of 124). No patients were lost before the minimum study follow-up of 2 years without having reached a study endpoint (reinfection or persistent PJI) or had incomplete datasets, leaving 74% (92 of 124) for analysis here. The median (range) time from the index surgery (previous primary, debridement, or revision procedure) to the current revision for PJI in these patients was 16 months (2 to 180). Of the included patients, 40% (37 of 92) were men, 39% (36 of 92) had PJI of the hip, and 61% (56 of 92) had PJI of the knee. The mean age of patients was 65 ± 13 years, and the mean BMI was 28 ± 3 kg/m 2 . The interval between two cultures was at least 1 hour, and one culture was taken from each of the patient's arms. Patients were divided into blood culture-positive and blood culture-negative groups based on preoperative blood culture results. The chi-square test and the independent t-test were used to compare demographic characteristics (gender, age, BMI, and affected joint) and clinical factors (American Society of Anesthesiologists [ASA] classification, hematological tests, comorbidities) between the two groups. Further multivariable logistic regression analysis was performed to assess the factors associated with positive blood cultures, which controlled for potential confounders including age, gender, BMI, and affected joint. The Firth penalized likelihood was employed when there was monotone likelihood in logistic regression analysis to reduce small-sample bias. A Kaplan-Meier curve tracked infection-free implant survival over 30 months, with differences evaluated using the log-rank test. RESULTS: Overall, 15% (14 of 92) of patients had positive blood cultures. After adjusting for age, gender, infection site, BMI, and intraoperative isolation of gram-positive cocci, we found that patients classified as ASA III (OR 4 [95% confidence interval (CI) 1 to 21]; p = 0.04) and those who had diabetes (OR 14 [95% CI 3 to 100]; p < 0.001) had a higher odds of positive blood cultures. We found no difference in the Kaplan-Meier estimate for infection-free implant survival at 30 months between those with positive blood cultures (86% [95% CI 76% to 95%]) and those with negative blood cultures (91% [95% CI 88% to 94%]; p = 0.51). CONCLUSION: In this prospective, observational study, we found that chronic PJI can potentially lead to hematogenous dissemination of pathogens, particularly in patients with poor overall health (such as those classified as ASA III and patients diagnosed with diabetes). Therefore, selective preoperative blood cultures may be crucial in helping clinicians implement early intervention measures to prevent the serious consequences of bacteremia in patients with poor baseline health and those with other implanted devices. Larger studies with longer follow-up are needed to further validate these findings, ensure more robust estimates, and conduct comprehensive evaluations of the risk factors associated with positive blood cultures in chronic PJI. LEVEL OF EVIDENCE: Level II, therapeutic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Ji B, Perry KI, Li G, et al. How Often Does Bacteremia Occur in Patients With Chronic Periprosthetic Joint Infection? A Prospective, Observational Study. Clin Orthop Relat Res. 2025. PMID: 39843348. doi:10.1097/CORR.0000000000003367

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。